William Richard White, Chief Financial Officer at Akero Therapeutics, Inc. (AKRO), sold 5,662 shares at $22.64 ($128K) on 2024-06-11, disclosed to the SEC on 2024-06-13.
Open-market sale of $128k AKRO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.64 | 2,831 | $64K | 50.0% |
| 2 | $22.64 | 2,831 | $64K | 50.0% |
| Total | $22.64 avg | 5,662 | $128K | 100% |
| Filing → |
| AKRO | SELL | 2025-06-12 | $151K | — | Filing → |
| AKRO | SELL | 2025-03-14 | $30K | — | Filing → |
| AKRO | SELL | 2024-12-12 | $173K | — | Filing → |